Full Text (PDF)
Original Article

A Study on the Various Treatment Modalities of Fournier‘S Gangrene

Sagar Mugadur* , Sagar Mugadur* , Sharath Kumar K.L.**

Author Information

Licence:




New Indian Journal of Surgery 7(2):p 107-109, May-Aug 2016. | DOI: DOI: https://dx.doi.org/10.21088/nijs.0976.4747.7216.4

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

 Introduction: gangrene is a rare and potentially fatal infectious disease characterized bynecrotizing fasciitis of the perineum and abdominal wall ina ddition to the scrotum andpenis in men and the vulva in women. To repair the scrotal and perineal defects remains asurgical challenge. Methods: This is a prospective study, includes 30 patients who were diagnosed as Fournier’s Gangrene. Allpatients were admitted and were subjected to routine investigation such as BC, TLC, DLC, C/S, ECG,CXR, HIV. The choice of reconstructive procedure was basedon the size, location, severity of defects and availability of local tissue. Post operativefollow up was done to note the complications both in hospital and after discharge for 6-12 months. Results: various reconstructive procedures were performed (Table 8), with special emphasis on flaps, constituting 16cases (53.33%) of flaps. Mean hospital stay duration was 30.6 ± 9.32days (range, 19- 3days). Conclusions: Management of this infectious entity should be aggressive. Several techniques that areused to reconstruct the lost tissue have shown good results.

Keywords: Fournier’s Gangrene; Scrotum; Bilateral Superomedial Thigh Flap.


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI: DOI: https://dx.doi.org/10.21088/nijs.0976.4747.7216.4

Keywords


Article Level Metrics

Last Updated

Thursday 30 July 2026, 00:31:47 (IST)


3364

Accesses

5
295
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share